(Q81661583)

English

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age

scientific article published on 01 May 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Comparison of the immunogenicity and reactogenicity of two commercially available hexavalent vaccines administered as a primary vaccination course at 2, 4 and 6 months of age (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Tichmann I

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Preidel H

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Grunert D

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Habash S

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Schult R

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Maier R

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Gildberg PK

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sengespeik HC

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Meurice F

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sänger R

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 May 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

number of pages

8

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

23

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

25

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

3272-3279

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

A Controlled Trial of Two Acellular Vaccines and One Whole-Cell Vaccine against Pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

A comparative efficacy trial in Germany in infants who received either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP vaccine, or DT vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Systematic review of the effects of pertussis vaccines in children.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Development and clinical testing of multivalent vaccines based on a diphtheria–tetanus–acellular pertussis vaccine: difficulties encountered and lessons learned

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Immunogenicity and safety of a new liquid hexavalent combined vaccine compared with separate administration of reference licensed vaccines in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Primary vaccination of infants with diphtheria-tetanus-acellular pertussis-hepatitis B virus- inactivated polio virus and Haemophilus influenzae type b vaccines given as either separate or mixed injections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Immunogenicity and reactogenicity of a novel hexavalent DTPa-HBV-IPV/Hib vaccine compared to separate concomitant injections of DTPa-IPV/Hib and HBV vaccines, when administered according to a 3, 5 and 11 month vaccination schedule

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Comparison of the reactogenicity and immunogenicity of a combined diphtheria, tetanus, acellular pertussis, hepatitis B, inactivated polio (DTPa-HBV-IPV) vaccine, mixed with the Haemophilus influenzae type b (Hib) conjugate vaccine and administered

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Safety and immunogenicity of a combined pentavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus and Haemophilus influenzae type b-tetanus conjugate vaccine in infants, compared with a whole cell pertussis pentavalent vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

A new DTPa-HBV-IPV vaccine co-administered with Hib, compared to a commercially available DTPw-IPV/Hib vaccine co-administered with HBV, given at 6, 10 and 14 weeks following HBV at birth.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. I. Studies on factors affecting the toxin and antitoxin titration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Micro cell culture method for determination of diphtheria toxin and antitoxin titres using VERO cells. II. Comparison with the rabbit skin method and practical application for seroepidemiological studies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Natural history of pertussis antibody in the infant and effect on vaccine response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Detection of delayed vaccinations: a new approach to visualize vaccine uptake

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Are booster immunisations needed for lifelong hepatitis B immunity?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Resurgence of diphtheria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

The changing epidemiology of diphtheria in the vaccine era.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Low levels of antipertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

A search for serologic correlates of immunity to Bordetella pertussis cough illnesses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Comparative efficacy of acellular pertussis vaccines: an analysis of recent trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Pertussis: current concepts of pathogenesis and prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Effects of adsorption of acellular pertussis antigens onto different aluminium salts on the protective activity in an intranasal murine model of Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Large scale safety study of a liquid hexavalent vaccine (D-T-acP-IPV-PRP--T-HBs) administered at 2, 4, 6 and 12-14 months of age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.087

7 January 2021

Identifiers

10.1016/J.VACCINE.2005.01.087

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15837232%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81661583&oldid=1775326465"